Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News KORU Medical Systems Inc KRMD

Healthcare Medical Devices
KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. The Company is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge... see more

Recent & Breaking News (NDAQ:KRMD)

KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin

Business Wire March 6, 2024

KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

Business Wire February 21, 2024

KORU Medical Systems to Participate in Piper Sandler's 35th Annual Healthcare Conference

Business Wire November 29, 2023

KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023

Business Wire November 28, 2023

KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System

Business Wire November 8, 2023

KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer

Business Wire November 8, 2023

KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook

Business Wire November 8, 2023

KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes

Business Wire November 7, 2023

KORU Medical Systems to Participate in Upcoming Investor Conferences

Business Wire November 2, 2023

KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023

Business Wire October 25, 2023

KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference

Business Wire October 5, 2023

KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors

Business Wire October 4, 2023

KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase

Business Wire September 15, 2023

KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook

Business Wire August 9, 2023

KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference

Business Wire August 8, 2023

KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates

Business Wire August 2, 2023

KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023

Business Wire July 31, 2023

KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic

Business Wire July 27, 2023

KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes

Business Wire July 10, 2023

KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer

Business Wire June 27, 2023